Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1168 | 986 | 1168 | 1057 | 1771 | 3440 |
Fund Return | 16.82% | -1.4% | 16.82% | 1.87% | 12.11% | 13.15% |
Place in category | 152 | 206 | 152 | 171 | 50 | 11 |
% in Category | 41 | 53 | 41 | 46 | 21 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.36B | 12.69 | 5.65 | 10.55 | ||
T. Rowe Price Blue Chip Growth | 33.29B | 35.63 | 7.54 | 14.89 | ||
T. Rowe Price Blue Chip Growth I | 29.84B | 35.79 | 7.68 | - | ||
T. Rowe Price Capital AppreciationI | 29.12B | 12.84 | 5.78 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.35B | 30.99 | 7.47 | 16.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds New Perspective A | 61.78B | 16.79 | 2.57 | 11.12 | ||
American Funds New Perspective R6 | 38.2B | 17.16 | 2.90 | 11.47 | ||
Old Westbury Large Cap Strategies | 24.78B | 20.86 | 4.06 | 8.00 | ||
American Funds New Perspective F2 | 19.22B | 17.01 | 2.79 | 11.35 | ||
American Funds New Economy A | 17.71B | 23.66 | 3.93 | 11.21 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.00 | 725.72 | -4.21% | |
Microsoft | US5949181045 | 4.49 | 429.03 | +1.05% | |
NVIDIA | US67066G1040 | 3.73 | 137.71 | +3.10% | |
Apple | US0378331005 | 3.42 | 229.98 | +0.75% | |
Amazon.com | US0231351067 | 3.02 | 225.94 | +2.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review